Silence Therapeutics Plc (SLNCF)
3.85
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Silence Therapeutics Net Income (TTM) : -59.95M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -59.95M |
| March 31, 2026 | -75.04M |
| December 31, 2025 | -88.61M |
| September 30, 2025 | -111.96M |
| June 30, 2025 | -110.64M |
| March 31, 2025 | -85.59M |
| September 30, 2024 | -74.94M |
| Date | Value |
|---|---|
| June 30, 2024 | -50.27M |
| March 31, 2024 | -43.65M |
| December 31, 2023 | -53.74M |
| September 30, 2023 | -52.00M |
| June 30, 2023 | -49.91M |
| March 31, 2023 | -51.87M |
| December 31, 2022 | -49.77M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | -5.93M |
| NuCana Plc | -13.03M |
| Mereo BioPharma Group Plc | -28.05M |
| Compass Pathways Plc | -407.35M |
| HemoGenyx Pharmaceuticals Plc | -15.20M |